Jun 21, 2022

Featuring perspectives from Prof Harry Yoon, including the following topics:

• Introduction (0:00)
• Case: A woman in her late 30s with Stage IIIA HER2-negative adenocarcinoma of the gastric antrum (pMMR, PD-L1 CPS <1) — Lionel A Kankeu Fonkoua, MD (11:31)
• Case: A man in his mid 70s with metastatic esophageal adenocarcinoma (PD-L1 CPS 5) — Gurveen Kaur, MD (16:01)
• Case: A man in his mid 70s with HER2-negative gastroesophageal junction adenocarcinoma with multiple brain metastases (microsatellite stable, PD-L1 CPS 10) — Neil Morganstein, MD (29:00)
• Case: A man in his early 60s with HER2-positive esophageal adenocarcinoma (PD-L1 70%) — Kapisthalam (KS) Kumar, MD (42:19)
• Case: A man in his early 60s with HER2-positive metastatic gastric cancer — Dr Morganstein (49:37)

CME information and select publications